We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

FLUOROCHEM:NSEGujarat Fluorochemicals Ltd. Analysis

Data as of 2026-05-17 - not real-time

₹3,713.80

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Gujarat Fluorochemicals is trading at ₹3,713, comfortably above its 20‑day (₹3,561) and 50‑day (₹3,363) SMAs, with the 20‑day SMA also above the 200‑day SMA (₹3,479), indicating a short‑term bullish bias. The RSI sits at 64 and the MACD histogram is positive, while recent chart patterns suggest a breakout above a medium‑term downtrendline, reinforcing the momentum view. However, the stock carries a steep valuation – a trailing PE of 62× and a price‑to‑book of 5.35× – and a heavily leveraged balance sheet (debt‑to‑equity ≈ 22.5×). The dividend yield is a modest 0.08% with a payout ratio of just 5%, raising questions about its sustainability. Volatility remains elevated at ~29% over the past 30 days, though beta is low at 0.21, indicating limited market‑wide systematic risk.
Given the strong technical setup and a positive analyst consensus (Buy), the near‑term outlook is supportive, but the high valuation, weak cash generation and substantial debt temper enthusiasm for longer horizons. Investors should weigh the upside from momentum against the downside risk from financial leverage and limited growth prospects.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Bullish technical indicators (price above SMAs, positive MACD, RSI in bullish range)
  • Recent breakout above medium‑term trendline
  • Forward EPS guidance improving, supporting upside potential

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Elevated valuation multiples relative to earnings
  • High debt load limiting financial flexibility
  • Stable but modest operating margins and flat revenue growth

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Significant leverage (debt‑to‑equity > 20) and limited cash generation
  • Low dividend yield and questionable sustainability
  • Potential regulatory and environmental headwinds in the specialty chemicals sector

Key Metrics & Analysis

Financial Health

Revenue Growth-1.00%
Profit Margin13.52%
P/E Ratio62.1
Debt/Equity22.48
P/B Ratio5.4

Technical Analysis

TrendNeutral
RSI63.9
Support₹3,250.50
Resistance₹3,878.00
MA 20₹3,560.79
MA 50₹3,362.64
MA 200₹3,478.78
MACDBullish
VolumeStable
Fear & Greed Index88.52

Valuation

Target Price₹3,660.29
Upside/Downside-1.44%
GradeOvervalued
TypeValue
Dividend Yield0.08%

Risk Assessment

Beta0.21
Volatility28.84%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.